EMU061331
MISSION® esiRNA
targeting mouse Irs1
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.51
UNSPSC Code:
41105324
description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
TGACCTCAGCAAATCCTCCTTTTAACTCATGGGTACCCAGACTCGAACTATTTCACAATTCACAACCAGGACCTCACGTCTTCCTCTTCAGTAGATGGTACGATGCATCCGTTACAGTTTTGTTTACCTTGTACAATCCTCAGGAGTTCATTGACTGAACTGCACGTTGTACATTGTGCCAAGCAACAAGAAAGCACTGTGACACCGGAACAATTAGTGTGCATAAACTTCATCTTGAACTTTAAGGACAGCTGGTCACGAAGAGCTGGTGCACTTCCTACCACCAAGAGAATGGGTTTACTCTCATCAAATTTGCAACCGACGTTTCCTCTACTCTGAAACCGTGTTCCATGATGCGCCTCTGTAAATTACTCCATATGGAACTGTTCATGTTGGGTGGAGA
Ensembl | mouse accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
mouse ... IRS1(16367), Irs1(16367)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
Storage Class
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
M Slevin et al.
Scientific reports, 5, 13281-13281 (2015-09-04)
Alzheimer's disease (AD) increases dramatically in patients with ischaemic stroke. Monomeric C-reactive protein (mCRP) appears in the ECM of ischaemic tissue after stroke, associating with microvasculature, neurons and AD-plaques, Aβ, also, being able to dissociate native-CRP into inflammatory, mCRP in
Kassondra Meyer et al.
Molecular and cellular biology, 35(17), 2991-3004 (2015-06-24)
Loss of repressor element 1 silencing transcription factor (REST) occurs in 20% of breast cancers and correlates with a poor patient prognosis. However, the molecular basis for enhanced malignancy in tumors lacking REST (RESTless) is only partially understood. We used
Global Trade Item Number
| SKU | GTIN |
|---|---|
| EMU061331-20UG | 04061831338713 |
| EMU061331-50UG | 04061831369809 |